These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11728230)

  • 1. Gene transfer to induce angiogenesis in myocardial and limb ischaemia.
    Laham RJ; Mannam A; Post MJ; Sellke F
    Expert Opin Biol Ther; 2001 Nov; 1(6):985-94. PubMed ID: 11728230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia.
    Schratzberger P; Kirchmair R; Vale PR; Losordo DW
    Curr Pharm Des; 2003; 9(13):1041-7. PubMed ID: 12678856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
    Rissanen TT; Rutanen J; Ylä-Herttuala S
    Adv Genet; 2004; 52():117-64. PubMed ID: 15522734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
    Theurl M; Schgoer W; Albrecht-Schgoer K; Lener D; Wolf D; Wolf M; Demetz E; Tymoszuk P; Tancevski I; Fischer-Colbrie R; Franz WM; Marschang P; Kirchmair R
    Cardiovasc Res; 2015 Jan; 105(1):96-106. PubMed ID: 25377726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia.
    Maulik N
    Curr Opin Investig Drugs; 2009 Mar; 10(3):259-68. PubMed ID: 19333884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis for peripheral artery disease: gene therapy.
    Nikol S
    Vasa; 2007 Aug; 36(3):165-73. PubMed ID: 18019272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis for critical limb ischemia.
    Ko SH; Bandyk DF
    Semin Vasc Surg; 2014 Mar; 27(1):23-31. PubMed ID: 25812756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for collateral vessel development.
    Melillo G; Scoccianti M; Kovesdi I; Safi J; Riccioni T; Capogrossi MC
    Cardiovasc Res; 1997 Sep; 35(3):480-9. PubMed ID: 9415292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Worldwide experience and recent trends in gene therapy of ischaemic diseases].
    Deev RV; Grigorian AS; Potapov IV; Kiselev SL; Isaev AA
    Angiol Sosud Khir; 2011; 17(2):145-54. PubMed ID: 21998874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy.
    Markkanen JE; Rissanen TT; Kivelä A; Ylä-Herttuala S
    Cardiovasc Res; 2005 Feb; 65(3):656-64. PubMed ID: 15664392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for myocardial angiogenesis.
    Losordo DW; Vale PR; Isner JM
    Am Heart J; 1999 Aug; 138(2 Pt 2):S132-41. PubMed ID: 10426872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.
    Emanueli C; Madeddu P
    Vascul Pharmacol; 2006 Nov; 45(5):334-9. PubMed ID: 17008132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease.
    Isner JM; Walsh K; Symes J; Pieczek A; Takeshita S; Lowry J; Rosenfield K; Weir L; Brogi E; Jurayj D
    Hum Gene Ther; 1996 May; 7(8):959-88. PubMed ID: 8727509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease.
    Kapur NK; Rade JJ
    Trends Cardiovasc Med; 2008 May; 18(4):133-41. PubMed ID: 18555186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived endothelial cell growth factor gene therapy for limb ischemia.
    Yamada N; Li W; Ihaya A; Kimura T; Morioka K; Uesaka T; Takamori A; Handa M; Tanabe S; Tanaka K
    J Vasc Surg; 2006 Dec; 44(6):1322-8. PubMed ID: 17145437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and overcoming obstacles in angiogenic gene therapy for myocardial ischemia.
    Rubanyi GM
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):109-19. PubMed ID: 24736636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia.
    Heinl-Green A; Radke PW; Munkonge FM; Frass O; Zhu J; Vincent K; Geddes DM; Alton EW
    Eur Heart J; 2005 Jul; 26(13):1327-32. PubMed ID: 15821009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for critical limb ischemia: invited commentary.
    Messina LM; Brevetti LS; Chang DS; Paek R; Sarkar R
    J Control Release; 2002 Jan; 78(1-3):285-94. PubMed ID: 11772469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121.
    Patel SR; Lee LY; Mack CA; Polce DR; El-Sawy T; Hackett NR; Ilercil A; Jones EC; Hahn RT; Isom OW; Rosengart TK; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1331-48. PubMed ID: 10365664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.